American Portfolios Advisors Adverum Biotechnologies, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Adverum Biotechnologies, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 1,150 shares of ADVM stock, worth $8,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,150Holding current value
$8,521% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding ADVM
# of Institutions
4Shares Held
2.53MCall Options Held
0Put Options Held
0About Adverum Biotechnologies, Inc.
- Ticker ADVM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 99,333,600
- Market Cap $736M
- Description
- Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...